Literature DB >> 17496918

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.

S Meloche1, J Pouysségur.   

Abstract

The Ras-dependent extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein (MAP) kinase pathway plays a central role in cell proliferation control. In normal cells, sustained activation of ERK1/ERK2 is necessary for G1- to S-phase progression and is associated with induction of positive regulators of the cell cycle and inactivation of antiproliferative genes. In cells expressing activated Ras or Raf mutants, hyperactivation of the ERK1/2 pathway elicits cell cycle arrest by inducing the accumulation of cyclin-dependent kinase inhibitors. In this review, we discuss the mechanisms by which activated ERK1/ERK2 regulate growth and cell cycle progression of mammalian somatic cells. We also highlight the findings obtained from gene disruption studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496918     DOI: 10.1038/sj.onc.1210414

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  413 in total

1.  Single-cell mass cytometry of TCR signaling: amplification of small initial differences results in low ERK activation in NOD mice.

Authors:  Michael Mingueneau; Smita Krishnaswamy; Matthew H Spitzer; Sean C Bendall; Erica L Stone; Stephen M Hedrick; Dana Pe'er; Diane Mathis; Garry P Nolan; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses.

Authors:  Timothy Q Crawford; Lishomwa C Ndhlovu; Alice Tan; Alex Carvidi; Frederick M Hecht; Elizabeth Sinclair; Jason D Barbour
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells.

Authors:  Rulan Jiang; Veronica Lopez; Shannon L Kelleher; Bo Lönnerdal
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

4.  Data-driven modelling of receptor tyrosine kinase signalling networks quantifies receptor-specific potencies of PI3K- and Ras-dependent ERK activation.

Authors:  Murat Cirit; Jason M Haugh
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

5.  Nek10 mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation.

Authors:  Larissa S Moniz; Vuk Stambolic
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

6.  Control of FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells.

Authors:  R Yerbes; A López-Rivas; M J Reginato; C Palacios
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

7.  Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel.

Authors:  James H Doroshow; Agnes Juhasz; Yun Ge; Susan Holbeck; Jiamo Lu; Smitha Antony; Yongzhong Wu; Guojian Jiang; Krishnendu Roy
Journal:  Biochem Pharmacol       Date:  2012-01-24       Impact factor: 5.858

8.  A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.

Authors:  Seyyed Mehdi Jafari; Hamid Reza Joshaghani; Mojtaba Panjehpour; Mahmoud Aghaei
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

9.  Oxygen-Glucose Deprivation Induces G2/M Cell Cycle Arrest in Brain Pericytes Associated with ERK Inactivation.

Authors:  Wenjie Wei; Zhiyuan Yu; Minjie Xie; Wei Wang; Xiang Luo
Journal:  J Mol Neurosci       Date:  2016-09-24       Impact factor: 3.444

10.  Decreased proliferative capacity of aged dermal fibroblasts in a three dimensional matrix is associated with reduced IGF1R expression and activation.

Authors:  Itay Bentov; Mamatha Damodarasamy; Stephen Plymate; May J Reed
Journal:  Biogerontology       Date:  2014-04-26       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.